Company: DHR
Filing Date: 2025-07-22
Form Type: 10-Q
Source: 0000313616-25-000153
Chunk: 108

Company: DANAHER CORP /DE/
Filing Date: 2025-07-22
Form: 10-Q
Item: Item 8
Chunk 108
---
reciation38 35 72 77 Amortization of intangible assets228 214 441 432 Operating profit as a % of sales28.7 %27.0 %28.1 %24.3 %Depreciation as a % of sales2.1 %2.0 %2.1 %2.4 %Amortization as a % of sales12.3 %12.5 %12.7 %13.3 %

Sales Growth and Core Sales Growth% Change Three-Month Period Ended June 27, 2025 vs. Comparable 2024 Period% Change Six-Month Period Ended June 27, 2025 vs. Comparable 2024 PeriodTotal sales growth (GAAP)8.0 %7.0 %Impact of:Currency exchange rates (2.0)%(0.5)%Core sales growth (non-GAAP)6.0 %6.5 %

Price increases in the segment contributed 2.5% and 2.0%, respectively, to sales growth on a year-over-year basis during the three and six-month periods ended June 27, 2025 and are reflected as a component of core sales above.

Total segment sales increased 8.0% and 7.0% during the three and six-month periods, respectively.  The increase in segment sales in the three and six-month periods was led by increased core sales and to a lesser extent by the impact of currency exchange rates.  The year-over-year increase in total segment core sales was led by increased sales of consumables, partially offset by declines in equipment sales in both periods.  Geographically, the increase in core sales was led by Western Europe in both periods.  

The year-over-year increase in core sales in the segment was led by the bioprocessing business in both the three and six-month periods and was primarily driven by improved consumables demand from large pharmaceutical customers, primarily in Western Europe, partially offset by lower demand for equipment across most major markets.  Core sales in the discovery and medical business decreased year-over-year as lower demand for equipment in the life science research end-markets more than offset the improved demand for consumables.  

Operating Profit Performance

Operating profit margins increased 170 basis points during the three-month period ended June 27, 2025 as compared to the comparable period of 2024 due to higher 2025 core sales, the impact of product mix